These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9316002)

  • 21. [Neuroleptic adverse effects with emphasis on weight gain].
    Hebebrand J
    Z Kinder Jugendpsychiatr Psychother; 2009 Jul; 37(4):321-4. PubMed ID: 20306798
    [No Abstract]   [Full Text] [Related]  

  • 22. Antipsychotic drugs and diabetes.
    McIntyre RS
    CMAJ; 2003 Mar; 168(6):673. PubMed ID: 12642417
    [No Abstract]   [Full Text] [Related]  

  • 23. The influence of 5-HT(2C) and MDR1 genetic polymorphisms on antipsychotic-induced weight gain in female schizophrenic patients.
    Kuzman MR; Medved V; Bozina N; Hotujac L; Sain I; Bilusic H
    Psychiatry Res; 2008 Sep; 160(3):308-15. PubMed ID: 18718676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antipsychotic-induced dyslipidemia treated with omega 3 fatty acid supplement in an 11-year-old psychotic child: a 1-year follow-up.
    Pisano S; Gritti A; Catone G; Pascotto A
    J Child Adolesc Psychopharmacol; 2013 Mar; 23(2):139-41. PubMed ID: 23480323
    [No Abstract]   [Full Text] [Related]  

  • 25. Dose-dependent acute excessive weight gain and metabolic changes in a drug-naive patient on risperidone are reversible with discontinuation: a case report.
    Sahoo S; Mishra B; Akhtar S
    Br J Clin Pharmacol; 2007 Nov; 64(5):715-6. PubMed ID: 17509037
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy and tolerability of Blonanserin in the patients with schizophrenia: a randomized, double-blind, risperidone-compared trial.
    Yang J; Bahk WM; Cho HS; Jeon YW; Jon DI; Jung HY; Kim CH; Kim HC; Kim YK; Kim YH; Kwon JS; Lee SY; Lee SH; Yi JS; Yoon BH; Kim SH
    Clin Neuropharmacol; 2010 Jul; 33(4):169-75. PubMed ID: 20661022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Weight gain in a controlled study of risperidone in children, adolescents and adults with mental retardation and autism.
    Hellings JA; Zarcone JR; Crandall K; Wallace D; Schroeder SR
    J Child Adolesc Psychopharmacol; 2001; 11(3):229-38. PubMed ID: 11642473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Weight gain associated with clozapine, olanzapine and risperidone in children and adolescents.
    Fleischhaker C; Heiser P; Hennighausen K; Herpertz-Dahlmann B; Holtkamp K; Mehler-Wex C; Rauh R; Remschmidt H; Schulz E; Warnke A
    J Neural Transm (Vienna); 2007 Feb; 114(2):273-80. PubMed ID: 17109073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel antipsychotics: comparison of weight gain liabilities.
    Wirshing DA; Wirshing WC; Kysar L; Berisford MA; Goldstein D; Pashdag J; Mintz J; Marder SR
    J Clin Psychiatry; 1999 Jun; 60(6):358-63. PubMed ID: 10401912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Weight and leptin changes among risperidone-treated youths with autism: 6-month prospective data.
    Martin A; Scahill L; Anderson GM; Aman M; Arnold LE; McCracken J; McDougle CJ; Tierney E; Chuang S; Vitiello B
    Am J Psychiatry; 2004 Jun; 161(6):1125-7. PubMed ID: 15169706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A crossover study of risperidone in children, adolescents and adults with mental retardation.
    Hellings JA; Zarcone JR; Reese RM; Valdovinos MG; Marquis JG; Fleming KK; Schroeder SR
    J Autism Dev Disord; 2006 Apr; 36(3):401-11. PubMed ID: 16596465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Weight gain in adolescents treated with risperidone and conventional antipsychotics over six months.
    Kelly DL; Conley RR; Love RC; Horn DS; Ushchak CM
    J Child Adolesc Psychopharmacol; 1998; 8(3):151-9. PubMed ID: 9853689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risperidone side effects.
    Conley RR
    J Clin Psychiatry; 2000; 61 Suppl 8():20-3; discussion 24-5. PubMed ID: 10811239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risperidone induced weight gain leading to benign intracranial hypertension.
    Ahmed H; Ali H
    BMJ Case Rep; 2011 Jul; 2011():. PubMed ID: 22689727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relative weight gain among antipsychotics.
    Masand PS
    J Clin Psychiatry; 1999 Oct; 60(10):706-8. PubMed ID: 10549690
    [No Abstract]   [Full Text] [Related]  

  • 36. A retrospective comparison of BMI changes and the potential risk factors among schizophrenic inpatients treated with aripiprazole, olanzapine, quetiapine or risperidone.
    Lee SY; Park MH; Patkar AA; Pae CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):490-6. PubMed ID: 21146575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TNF-α -308 G>A polymorphism and weight gain in patients with schizophrenia under long-term clozapine, risperidone or olanzapine treatment.
    Huang HH; Wang YC; Wu CL; Hong CJ; Bai YM; Tsai SJ; Liou YJ
    Neurosci Lett; 2011 Oct; 504(3):277-80. PubMed ID: 21967963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Weight change and atypical antipsychotic treatment in patients with schizophrenia.
    Jones B; Basson BR; Walker DJ; Crawford AM; Kinon BJ
    J Clin Psychiatry; 2001; 62 Suppl 2():41-4. PubMed ID: 11232752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antipsychotic-induced body weight gain: predictors and a systematic categorization of the long-term weight course.
    Gebhardt S; Haberhausen M; Heinzel-Gutenbrunner M; Gebhardt N; Remschmidt H; Krieg JC; Hebebrand J; Theisen FM
    J Psychiatr Res; 2009 Mar; 43(6):620-6. PubMed ID: 19110264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics.
    Atmaca M; Kuloglu M; Tezcan E; Ustundag B
    J Clin Psychiatry; 2003 May; 64(5):598-604. PubMed ID: 12755665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.